J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Rangering i aksjer
#3875
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Aksjekurs
$26.58
Sist synkronisert: 2026-07-23
Markedsverdi
$4.24B
Endring (1 dag)
0.00%
Endring (1 år)
38.14%
Land
IN
Handel J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Kategori
Healthcare
Utbyttehistorikk for J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
J. B. Chemicals & Pharmaceuticals Limited (aksjesymbol: JBCHEPHARM) har gitt totalt 36 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $111.78
Utbytteavkastning (TTM): 0.0091
Summen av alle utbytter (justert for aksjesplitt): $111.78
Utbytteavkastning (TTM): 0.0091
Utbyttebetalinger for J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM) fra 2003 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $12.70 | -18.06% |
| 2025 | $15.50 | 26.53% |
| 2024 | $12.25 | 38.03% |
| 2023 | $8.88 | 7.58% |
| 2022 | $8.25 | 0.00% |
| 2021 | $8.25 | 50.00% |
| 2020 | $5.50 | 120.00% |
| 2019 | $2.50 | 150.00% |
| 2018 | $1.00 | 100.00% |
| 2017 | $0.5 | -80.00% |
| 2016 | $2.50 | 25.00% |
| 2015 | $2.00 | 33.33% |
| 2014 | $1.50 | 0.00% |
| 2013 | $1.50 | 200.00% |
| 2012 | $0.5 | -97.62% |
| 2011 | $21.00 | 2,000.00% |
| 2010 | $1.00 | 100.00% |
| 2009 | $0.5 | 100.00% |
| 2008 | $0.25 | -66.67% |
| 2007 | $0.75 | -42.31% |
| 2006 | $1.30 | 4.00% |
| 2005 | $1.25 | 8.70% |
| 2004 | $1.15 | -8.00% |
| 2003 | $1.25 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $12.70 | -18.06% |
| 2025 | $15.50 | 26.53% |
| 2024 | $12.25 | -30.99% |
| 2023 | $17.75 | 7.58% |
| 2022 | $16.50 | 0.00% |
| 2021 | $16.50 | 50.00% |
| 2020 | $11.00 | 120.00% |
| 2019 | $5.00 | 150.00% |
| 2018 | $2.00 | 100.00% |
| 2017 | $1.00 | -80.00% |
| 2016 | $5.00 | 25.00% |
| 2015 | $4.00 | 33.33% |
| 2014 | $3.00 | 0.00% |
| 2013 | $3.00 | 200.00% |
| 2012 | $1.00 | -97.62% |
| 2011 | $42.00 | 2,000.00% |
| 2010 | $2.00 | 100.00% |
| 2009 | $1.00 | 100.00% |
| 2008 | $0.5 | -66.67% |
| 2007 | $1.50 | -42.31% |
| 2006 | $2.60 | 4.00% |
| 2005 | $2.50 | -78.26% |
| 2004 | $11.50 | -8.00% |
| 2003 | $12.50 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
